AU:DXB Stock Latest News
Company AnnouncementsDimerix Reports Former Director’s Option Interests After Retirement6d agoDXB
Company AnnouncementsDimerix strengthens balance sheet and kidney pipeline as ACTION3 hits key milestones1w agoDXB
Company AnnouncementsDimerix bolsters DMX-200 case with new FSGS inflammatory pathway data2w agoDXB
Company AnnouncementsDimerix targets rare kidney diseases as it steps up investor outreach in Australia and Hong Kong1M agoDXB
Company AnnouncementsDimerix Marks Four-Year Milestone in DMX-200 FSGS Clinical Program1M agoDXB
Company AnnouncementsDimerix Issues 9.35 Million Unquoted Options Under Employee Incentive Scheme1M agoDXBCompany AnnouncementsDimerix to Showcase Kidney Disease Pipeline and Growth Strategy at ASX SMIDcaps Conference1M agoDXB
Company AnnouncementsDimerix Secures A$17m Non‑Dilutive Funding to Drive Kidney Disease Trials1M agoDXB
Company AnnouncementsDimerix Wins ASX Waiver to Secure Related-Party Funding in A$50m Facility1M agoDXB
Company AnnouncementsDimerix to Showcase Kidney Disease Pipeline and Growth Strategy at E&P Healthcare Conference1M agoDXB
Company AnnouncementsDimerix Highlights Kidney Disease Focus and Development Risks in Investor Update2M agoDXB
Company AnnouncementsS&P Dow Jones Indices Unveils September 2026 Rebalance of S&P/ASX Benchmarks2M agoDXB
Company AnnouncementsDimerix lifts revenue but annual loss more than doubles2M agoDXB
Company AnnouncementsDimerix Secures US$10m Everest Payment as DMX-200 Global Strategy Advances2M agoDXB
Company AnnouncementsDimerix Takes Control of U.S. IND for New Renal Asset DMX-6522M agoDXB
Company AnnouncementsDimerix highlights kidney disease pipeline and diversification strategy at Bioshares Summit3M agoDXB
Company AnnouncementsDimerix to Highlight Kidney Disease Pipeline Progress at TechKnow Invest Conference3M agoDXBCompany AnnouncementsDimerix Secures Long-Term U.S. Patent Protection for Phase 2 Kidney Drug DMX-6523M agoDXB
Company AnnouncementsDimerix Strikes Major Asian Licensing Deal for Phase 3 Kidney Drug DMX-2004M agoDXB



